15 agosto 2014
An antibody against the protein EphA3, found in the micro-environment of solid cancers, has anti-tumor effects, an international team of scientists has shown. As EphA3 is present in normal organs only during embryonic development but is expressed in blood cancers and in solid tumors, this antibody-based approach may be a suitable candidate treatment for solid tumors.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/XbUE4gI9CE0/140815102231.htm
